fermenta-biotech-ltd

Fermenta Biotech Ltd Financials
Company Logo

Fermenta Biotech Ltd Financial Statement

Fermenta Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue92.49
Operating Expense74.05
Net Profit8.16
Net Profit Margin8.82
Earning Per Share2.81
EBIDTA18.44
Effective Tax Rate3.80

Fermenta Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual307.09
Operating Expenses Annual270.10
Operating Profit Annual36.14
Interest Annual17.05
Depreciation20.51
Net Profit Annual-18.74
Tax Annual14.14

Fermenta Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning14.54
Cash Flow from Operations105.02
Cash Flow from Investing-15.15
Cash Flow from Financing-90.86
Cash Flow at the End13.56

Fermenta Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)14.92
PBIT Margin (%)7.20
PBT Margin (%)6.79
Net PROFIT Margin (%)-6.10
Return On Networth / Equity (%)-2.38
Return On Networth /Employed (%)4.10
Return On Assets (%)-3.48
Total Debt / Equity (X)0.55
Asset Turnover Ratio (%)0.57

Fermenta Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual261.40
Total Current Assets Annual238.23
Non Current Assets Annual326.35
Total Shareholders Funds Annual314.23
Total Assets Annual564.58

Fermenta Biotech Ltd Earning Calls

EPS (INR)

Expected

3.92

Reported

3.94

Surprise

0.51%

Jun 2024

EPS beaten by 0.51%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Dec 11, 2024, Fermenta Biotech Ltd has a market capitalization of 445.59 Cr. Value Research classifies it as a Small-Cap company.
Yes, Fermenta Biotech Ltd is debt-free with a debt-to-equity ratio of 0.44.
In FY 2023 , Fermenta Biotech Ltd recorded a total revenue of approximately 307.09 Cr marking a significant milestone in the company's financial performance.
Fermenta Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and -0.1% annually, respectively..
Fermenta Biotech Ltd's current PE ratio is -23.78.
Fermenta Biotech Ltd's ROCE averaged 5.8% from the FY ending March 2022 to 2024, with a median of 4.4%. It peaked at 9.3% in March 2022, reflecting strong capital efficiency over the period..
Fermenta Biotech Ltd's latest EBIT is Rs. 12.44 Cr, surpassing the average EBIT of Rs. 11.68 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions